Brinzolamide(储存“2-8℃”;运输“冰袋”)
布林佐胺;(R)-(+)-4-乙胺基-2-(3-甲氧丙基)-3,4-二氢-2H-噻吩并[3,2-e]-1,2-噻嗪-6-磺酰胺-1,1-二氧化物;4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物;帕瑞唑胺;1,2,3-丙三醇脂十八碳烯酸异酯;Brinzolamide ; 布林佐胺;布林左胺;布林佐胺 USP标准品;布林佐胺杂质;布林佐胺中间体;派立明;派立明标准品;(R)-4-(乙氨基)-2-(3-甲氧基丙基)-3,4-二氢-2H-噻吩并[3,2-e][1,2]噻嗪-6-磺胺1,1-二氧化物;布林佐胺(标准品);布林佐胺(标准品);布林佐胺及中间体;布林佐胺及中间体;(R)-(+)-4-乙胺...;(R)-(+)-4-乙胺...;-4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物;-4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物 布林佐胺;(R)-(+)-4-乙胺基-2-(3-甲氧丙基)-3,4-二氢-2H-噻吩并[3,2-e]-1,2-噻嗪-6-磺酰胺-1,1-二氧化物;4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物;帕瑞唑胺;1,2,3-丙三醇脂十八碳烯酸异酯;Brinzolamide ; 布林佐胺;布林左胺;布林佐胺 USP标准品;布林佐胺杂质;布林佐胺中间体;派立明;派立明标准品;(R)-4-(乙氨基)-2-(3-甲氧基丙基)-3,4-二氢-2H-噻吩并[3,2-e][1,2]噻嗪-6-磺胺1,1-二氧化物;布林佐胺(标准品);布林佐胺(标准品);布林佐胺及中间体;布林佐胺及中间体;(R)-(+)-4-乙胺...;(R)-(+)-4-乙胺...;-4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物;-4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物 展开
138890-62-7
C12H21N3O5S3
383.51
中文名称 Brinzolamide(储存“2-8℃”;运输“冰袋”)
中文别名 布林佐胺;(R)-(+)-4-乙胺基-2-(3-甲氧丙基)-3,4-二氢-2H-噻吩并[3,2-e]-1,2-噻嗪-6-磺酰胺-1,1-二氧化物;4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物;帕瑞唑胺;1,2,3-丙三醇脂十八碳烯酸异酯;Brinzolamide ; 布林佐胺;布林左胺;布林佐胺 USP标准品;布林佐胺杂质;布林佐胺中间体;派立明;派立明标准品;(R)-4-(乙氨基)-2-(3-甲氧基丙基)-3,4-二氢-2H-噻吩并[3,2-e][1,2]噻嗪-6-磺胺1,1-二氧化物;布林佐胺(标准品);布林佐胺(标准品);布林佐胺及中间体;布林佐胺及中间体;(R)-(+)-4-乙胺...;(R)-(+)-4-乙胺...;-4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物;-4-(乙氨基)-3,4-二氢-2-(3-甲氧丙基)-2H-噻吩[3,2-E]-1,2-噻嗪-6-氨磺酰1,1-二氧化物
英文别名 Brinzolamide;BIRNZOLAMIDE;2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)-;2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (R)-;AL 4862;Brinlolamide;(R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide;(4R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide;(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide;AL-4862;(R)-(+)-4-ethylamino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide;Azopt;Azopt (TN);Brinzolamide (BRZ);Brinzolamide [USAN];(5R)-5-Ethylamino-3-(3-methoxypropyl)-2,2-dioxo-2?6,9-dithia-3-azabicyclo[4.3.0]nona-7,10-diene-8-sulfonamide;(R)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-Dioxide;(R)- 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide;H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)-;H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)-;Brinzolamide (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide;Brinzolamide (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide;ANTI-GAGE7 (C-TERM) antibody produced in rabbit;ANTI-GAGE7 (C-TERM) antibody produced in rabbit;Cancer/testis antigen 4.7;Cancer/testis antigen 4.7;CT4.7;CT4.7;G antigen 7;G antigen 7;GAGE-12I;GAGE-12I;Brinzolamida;CHEBI:3176;NCGC00179542-03;BRINZOLAMIDE [INN];SR-01000838832-2;MFCD08067749;AS-35084;138890-50-3;NS00009895;(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-2H,3H,4H-1$l^{6},7,2-thieno[3,2-e][1$l^{6},2]thiazine-6-sulfonamide;BRINZOLAMIDE [MART.];NSC 760050;(R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide 1,1-dioxide;BRINZOLAMIDE [EMA EPAR];D00652;CAS-138890-62-7;AKOS005145708;BRD-K74913225-001-13-2;AB00513824;AB00513824_06;AL4862;CHEMBL220491;BRINZOLAMIDE COMPONENT OF SIMBRINZA;NCGC00179542-10;(R)-3,4-Dihydro-4-ethylamino-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide;NSC-760050;3znc;(+)-4-ETHYLAMINO-3,4-DIHYDRO-2-(METHOXY)PROPYL-2H-THIENO[3,2-E]-1,2-THIAZINE-6-SULFONAMIDE-1,1-DIOXIDE;BRINZOLAMIDE [JAN];SCHEMBL24636;HMS1569I11;HY-B0588;BRINZOLAMIDE [WHO-DD];BRD-K74913225-001-12-4;Tox21_110722_1;SMR001233169;SR-01000838832;SPBio_002410;Q-200751;S01EC04;(R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide;(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-...
CAS No. 138890-62-7
分子式 C12H21N3O5S3
分子量 383.51
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS